Dextrose

Product manufactured by Hospira, Inc.

Application Nr Approved Date Route Status External Links
NDA019466 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Intravenous Solutions Containing Dextrose Are Indicated For Parenteral Replenishment Of Fluid And Minimal Carbohydrate Calories As Required By The Clinical Condition Of The Patient. In This Dosage Form, 5% Dextrose Injection, Usp Is Intended To Be Used As A Diluent For The Contents Of An Add-Vantage Vial, Or Single-Dose Vials With 20 Mm Closure Using The Add-Vantage Addaptor Tm .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dextrose Monohydrate

Comments